Compound information
- Natural Products
- ZC1324004
- Molecular Formula
- C22H33N3O5S
- Molecular Weight
- 451.214092156 g/mol
- Structure
-
- IUPAC Name
- tert-butyl 4-[4-(p-tolylsulfonyl)piperazine-1-carbonyl]piperidine-1-carboxylate
- InChI
- InChI=1S/C22H33N3O5S/c1-17-5-7-19(8-6-17)31(28,29)25-15-13-23(14-16-25)20(26)18-9-11-24(12-10-18)21(27)30-22(2,3)4/h5-8,18H,9-16H2,1-4H3
- InChI Key
- KUZWBMDLJFJQFG-UHFFFAOYSA-N
- SMILES
- Cc1ccc(S(=O)(=O)N2CCN(C(=O)C3CCN(C(=O)OC(C)(C)C)CC3)CC2)cc1
- Source
- ZINC000012938806
Warheads
- Carbamate
-
ADMET Property
Physicochemical Property
Property | Value | Property | Value |
---|---|---|---|
Heavy Atom Count | 31 | Ring Count | 3 |
Heteroatom Count | 9 | Rotatable Bond Count | 3 |
Hydrogen Bond Acceptor Count | 5 | Hydrogen Bond Donor Count | 0 |
Topological Polar Surface Area | 87.23 Å2 | LogP | 2.644 |
LogS | -3.852 | LogD | 3.329 |
Absorption
Property | Value | Property | Value |
---|---|---|---|
Pgp inhibitor | 0.098 | Pgp substrate | 0.922 |
HIA | 0.974 | F20 % | 0.992 |
F30 % | 0.867 | Caco-2 | -4.467 |
MDCK | -4.905 |
Distribution
Property | Value | Property | Value |
---|---|---|---|
BBB Penetration | 0.798 | PPB | 91.083 |
VD | 1.063 | Fu | 1.176 |
Metabolism
Property | Value | Property | Value |
---|---|---|---|
CYP1A2 inhibitor | 0.003 | CYP1A2 substrate | 0.398 |
CYP2A6 substrate | 0.434 | CYP2B6 substrate | 0.628 |
CYP2C19 inhibitor | 0.589 | CYP2C19 substrate | 0.722 |
CYP2C8 substrate | 0.523 | CYP2C9 inhibitor | 0.297 |
CYP2C9 substrate | 0.999 | CYP2D6 inhibitor | 0.05 |
CYP2D6 substrate | 0.729 | CYP2E1 substrate | 0.513 |
CYP3A4 inhibitor | 0.6 | CYP3A4 substrate | 1.0 |
Excretion
Property | Value | Property | Value |
---|---|---|---|
T1/2 | 0.227 | CL | 3.865 |
Toxicity
Property | Value | Property | Value |
---|---|---|---|
hERG Blockers | 0.786 | Hepatotoxicity | 0.988 |
Mutagenicity | 0.542 | Rat Oral Acute Toxicity | 0.175 |
FDAMDD | 0.266 | Skin Sensitization | 0.0 |
Carcinogenicity | 0.382 | Eye Corrosion | 0.002 |
Eye Irritation | 0.002 | Respiratory Toxicity | 0.019 |
Environmental Toxicity
Property | Value | Property | Value |
---|---|---|---|
Bioconcentration Factors | 0.319 | IGC50 | 3.04 |
LC50FM | -7.369 | LC50DM | -0.873 |
Tox21 Pathway
Property | Value | Property | Value |
---|---|---|---|
NR-AR | 0.24 | NR-AR-LBD | 0.284 |
NR-AhR | 0.026 | NR-Aromatase | 0.058 |
NR-ER | 0.258 | NR-ER-LBD | 0.421 |
NR-PPAR-gamma | 0.096 | SR-ARE | 0.784 |
SR-ATAD5 | 0.338 | SR-HSE | 0.118 |
SR-MMP | 0.013 | SR-p53 | 0.057 |
Similar covalent inhibitors
Similar covalent drugs
No similar covalent drugs found for this compound.